首页>
外国专利>
Use of epidermal growth factor receptor (EGFR) tyrosine kinease enzyme to treat invasive breast cancer
Use of epidermal growth factor receptor (EGFR) tyrosine kinease enzyme to treat invasive breast cancer
展开▼
机译:表皮生长因子受体(EGFR)酪氨酸激酶在治疗浸润性乳腺癌中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
An epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor is used in the manufacture of a medicament for use in (a) reducing the transformation of epithelial cells from a normal to a malignant state in an invasive breast cancer free human; and/or (b) reducing the transformation of epithelial cells from an intermediate state, between normal epithelium and malignant invasive epithelium, to a malignant state in an invasive breast cancer free human; and/or (c) causing substantial reversion of epithelial tissue back to a normal state from an intermediate state between normal epithelium and malignant invasive epithelium.
展开▼